Faculty Disclosures
| Charles S. DeCarli, MD, FAAN |
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH. |
| Norman L. Foster, MD, FAAN |
No disclosure on file
|
| William Jagust, MD |
No disclosure on file
|
| Jeffrey A. Kaye, MD, FAAN |
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
| David S. Knopman, MD, FAAN |
Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Ronald C. Petersen, MD, PhD, FAAN |
Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Dennis W. Dickson, MD |
Dr. Dickson has nothing to disclose. |
| Bradley F. Boeve, MD, FAAN |
Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
| Joseph E. Parisi, MD |
Dr. Parisi has nothing to disclose. |
| Eric M. Reiman, MD |
Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA. |
| Bruce R. Reed, PhD |
No disclosure on file
|
| Clifford R. Jack, Jr., MD |
The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic. |
| Keith A. Josephs, Jr., MD, FAAN |
Dr. Josephs has nothing to disclose. |
| Rosa M. Valerio, PhD |
No disclosure on file
|
| Dan M. Mungas, PhD |
Dr. Mungas has nothing to disclose. |
| Adam S. Fleisher, MD |
No disclosure on file
|
| Deniz Erten-Lyons, MD, FAAN |
Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals. |
| Thomas J. Montine, MD, PhD |
Dr. Montine has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enable Medicine. Dr. Montine has stock in Enable Medicine. The institution of Dr. Montine has received research support from NIH. The institution of Dr. Montine has received research support from MJFF. Dr. Montine has received intellectual property interests from a discovery or technology relating to health care. Dr. Montine has received publishing royalties from a publication relating to health care. |
| Michael W. Weiner, MD |
No disclosure on file
|
| Kejal Kantarci, MD |
The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. |
| Chester Mathis |
No disclosure on file
|
| Owen T. Carmichael, PhD |
No disclosure on file
|
| William E. Klunk, MD, PhD |
No disclosure on file
|
| Hiroko H. Dodge, PhD |
No disclosure on file
|
|
No disclosure on file
|
| Jennifer Whitwell, PhD |
Dr. Whitwell has nothing to disclose. |
| Sarah Farias |
No disclosure on file
|
| Randall L. Woltjer |
Randall L. Woltjer has nothing to disclose. |
| Srivadee Oravivattanakul, MD |
Dr. Oravivattanakul has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. |
| Megan T. Donnelly, DO |
Dr. Donnelly has received personal compensation for serving as an employee of Novant Health. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AndHealth. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Donnelly has a non-compensated relationship as a Communications Director with Southern Headache Society that is relevant to AAN interests or activities. |
| Ronnyson Grativvol, MD |
No disclosure on file
|
| Stephen Weigand |
Stephen Weigand has nothing to disclose. |